Search

In the advanced renal cell carcinoma (RCC) scenario, there are no consistent biomarkers to predict the clinical benefit patients derived from immune checkpoint blockade (ICB). Taking this into consideration, herein, we conducted a retrospective study in order to develop and validate a gene expression score for predicting clinical benefit to the anti-PD-1 antibody nivolumab in the context of patients diagnosed with advanced clear cell RCC enrolled in the CheckMate-009, CheckMate-010, and CheckMate-025 clinical trials. First, a three-gene expression score (3GES) with prognostic value for overall survival integrating HMGA1, NUP62, and ARHGAP42 transcripts was developed in a cohort of patients treated with nivolumab. Its prognostic value was then validated in the TCGA-KIRC cohort. Second, the predictive value for nivolumab was confirmed in a set of patients from the CheckMate-025 phase 3 clinical trial. Lastly, we explored the correlation of our 3GES with different clinical, molecular, and immune tumor characteristics. If the results of this study are definitively validated in other retrospective and large-scale, prospective studies, the 3GES will represent a valuable tool for guiding the design of ICB-based clinical trials in the aRCC scenario in the near future.

Abstract Purpose To determine whether hypercapnia is associated with risk of hospital readmission related to anorexia nervosa (AN) in children and adolescents. Methods We performed a prospective study of patients ≤ 18 years old admitted due to AN decompensation from November 2018 to October 2019. Both subtypes of AN, restricting subtype (AN-R) and binge-eating/purging subtype (AN-BP), were included. Study participants were evaluated upon admission, at discharge and six months after discharge. T-tests or Mann–Whitney U tests was used to compare means values. Pearson or Spearman correlations were used to measure the association between two variables. Logistic regression models were developed to evaluate the relationship between scoring methods and readmission. Results Of the 154 persons admitted during the study period, 131 met the inclusion criteria. Median age was 15.1 years. At admission, 71% of participants were malnourished and 33 (25%) had been previously admitted. We observed a marked decrease in venous pH and stable pCO2 elevation during follow-up period. Hypercapnia at discharge was associated with a twofold increased likelihood of readmission and the odds of readmission increased as discharge pCO2 rose. These findings did not depend on AN subtype or participant sex. Electrolytes persisted within the normal range. Conclusion Hypercapnia and respiratory acidosis are common alterations in children and adolescents hospitalized due to AN decompensation. Hypercapnia persists for at least 6 months after discharge despite clinical improvement and is associated with higher odds of readmission. This is the first study to identify an abnormal laboratory finding as a potential predictor of readmission in AN. Level of evidence IV: Multiple time series without intervention.

Despite the high success rates of dental implants, peri-implantitis is currently the most common complication in dental implantology. Peri-implantitis has an inflammatory nature, it is associated with the accumulation of plaque in the peri-implant tissues, and its evolution can be progressive depending on various factors, comorbidities, and poor oral health. Prophylaxis and different treatment methods have been widely discussed in recent decades, and surgical and non-surgical techniques present both advantages and disadvantages. In this work, a literature review of different studies on the application of adjuvant treatments, such as local and systemic antibiotics and antiseptic treatments, was conducted. Positive outcomes have been found in the short (up to one year after treatment) and long term (up to ten years after treatment) with combined therapies. However, there is still a need to explore new therapies based on the use of advanced drug delivery systems for the effective treatment of peri-implantitis in the long term and without relapses. Hence, micro- and nanoparticles, implants, and injectable hydrogels, among others, should be considered in future peri-implantitis treatment with the aim of enhancing overall therapy outcomes.

Pharmaceutical 3D printing (3DP) is one of the emerging enabling technologies of personalised medicines as it affords the ability to fabricate highly versatile dosage forms. In the past 2 years, national medicines regulatory authorities have held consultations with external stakeholders to adapt regulatory frameworks to embrace point-of-care manufacturing. The proposed concept of decentralized manufacturing (DM) involves the provision of feedstock intermediates (pharma-inks) prepared by pharmaceutical companies to DM sites for manufacturing into the final medicine. In this study, we examine the feasibility of this model, with respect to both manufacturing and quality control. Efavirenz-loaded granulates (0–35%w/w) were produced by a manufacturing partner and shipped to a 3DP site in a different country. Direct powder extrusion (DPE) 3DP was subsequently used to prepare printlets (3D printed tablets), with mass ranging 266–371 mg. All printlets released more than 80% drug load within the first 60 min of the in vitro drug release test. An in-line near-infrared spectroscopy system was used as a process analytical technology (PAT) to quantify the printlets' drug load. Calibration models were developed using partial least squares regression, which showed excellent linearity (R2 = 0.9833) and accuracy (RMSE = 1.0662). Overall, this work is the first to report the use of an in-line NIR system to perform real-time analysis of printlets prepared using pharma-inks produced by a pharmaceutical company. By demonstrating the feasibility of the proposed distribution model through this proof-of-concept study, this work paves the way for investigation of further PAT tools for quality control in 3DP point-of-care manufacturing.

Inkjet printing has been extensively explored in recent years to produce personalised medicines due to its low cost and versatility. Pharmaceutical applications have ranged from orodispersible films to complex polydrug implants. However, the multi-factorial nature of the inkjet printing process makes formulation (e.g., composition, surface tension, and viscosity) and printing parameter optimization (e.g., nozzle diameter, peak voltage, and drop spacing) an empirical and time-consuming endeavour. Instead, given the wealth of publicly available data on pharmaceutical inkjet printing, there is potential for a predictive model for inkjet printing outcomes to be developed. In this study, machine learning (ML) models (random forest, multilayer perceptron, and support vector machine) to predict printability and drug dose were developed using a dataset of 687 formulations, consolidated from in-house and literature-mined data on inkjet-printed formulations. The optimized ML models predicted the printability of formulations with an accuracy of 97.22%, and predicted the quality of the prints with an accuracy of 97.14%. This study demonstrates that ML models can feasibly provide predictive insights to inkjet printing outcomes prior to formulation preparation, affording resource- and time-savings.

Inkjet printing has the potential to advance the treatment of eye diseases by printing drugs on demand onto contact lenses for localised delivery and personalised dosing, while near-infrared (NIR) spectroscopy can further be used as a quality control method for quantifying the drug but has yet to be demonstrated with contact lenses. In this study, a glaucoma therapy drug, timolol maleate, was successfully printed onto contact lenses using a modified commercial inkjet printer. The drug-loaded ink prepared for the printer was designed to match the properties of commercial ink, whilst having maximal drug loading and avoiding ocular inflammation. This setup demonstrated personalised drug dosing by printing multiple passes. Light transmittance was found to be unaffected by drug loading on the contact lens. A novel dissolution model was built, and in vitro dissolution studies showed drug release over at least 3 h, significantly longer than eye drops. NIR was used as an external validation method to accurately quantify the drug dose. Overall, the combination of inkjet printing and NIR represent a novel method for point-of-care personalisation and quantification of drug-loaded contact lenses.

Introduction: In the treatment of patients with acute bronchiolitis there is great variability in clinical practice. Treatments whose efficacy has not been demonstrated are frequently used despite the recommendations contained in the Clinical Practice Guidelines. Material and methods: A quality improvement strategy is implemented in the care of patients with acute bronchiolitis in the Emergency Department, which is maintained for five years and is periodically updated to be increasingly restrictive regarding the use of bronchodilators. To evaluate the impact of the intervention, a retrospective study of the rates of prescription of bronchodilators in children diagnosed with acute bronchiolitis in the month of December of four epidemic periods (2012, 2014, 2016 and 2018) was carried out. Results: 1767 children are included. There were no differences regarding age, respiratory rate, oxygen saturation or the estimated severity in each of the study seasons. The use of salbutamol in the Emergency Department decreased from 51.2% (95% CI: 46.6–55.8%) in 2012 to 7.8% (95% CI: 5.7%–10.5%) in 2018 (P

Resumen: Introducción: En el tratamiento de los pacientes con bronquiolitis aguda existe una gran variabilidad de la práctica clínica y con frecuencia se utilizan de forma indiscriminada tratamientos cuya eficacia no está demostrada a pesar de las recomendaciones recogidas en las guías de práctica clínica. Material y métodos: Se implementó una estrategia de mejora de la calidad en la atención a los pacientes con bronquiolitis aguda en el Servicio de Urgencias que se mantuvo durante 5 años y se actualizó periódicamente para ser cada vez más restrictiva respecto al uso de tratamientos broncodilatadores. Para evaluar el impacto de la intervención se realizó un estudio descriptivo retrospectivo de las tasas de prescripción de broncodilatadores en los niños diagnosticados de bronquiolitis aguda en el mes de diciembre de 4 periodos epidémicos (2012, 2014, 2016 y 2018). Resultados: Se incluyó a 1.767 niños. No existieron diferencias respecto a edad, frecuencia respiratoria, saturación de oxígeno ni gravedad en cada una de las temporadas a estudio. El empleo de salbutamol en Urgencias descendió del 51,2% (IC del 95%: 46,6-55,8%) en 2012 al 7,8% (IC del 95%: 5,7-10,5%) en 2018 (p

Diabetes mellitus is a major health problem with increasing prevalence at a global level. The discovery of insulin in the early 1900s represented a major breakthrough in diabetes management, with further milestones being subsequently achieved with the identification of glucagon-like peptide-1 (GLP-1) and the introduction of GLP-1 receptor agonists (GLP-1 RAs) in clinical practice. Moreover, the subcutaneous delivery of biotherapeutics is a well-established route of administration generally preferred over the intravenous route due to better patient compliance and prolonged drug absorption. However, current subcutaneous formulations of GLP-1 RAs present pharmacokinetic problems that lead to adverse reactions and treatment discontinuation. In this review, we discuss the current challenges of subcutaneous administration of peptide-based therapeutics and provide an overview of the formulations available for the different routes of administration with improved bioavailability and reduced frequency of administration.

Recent advancements in next generation spacecrafts have reignited public excitement over life beyond Earth. However, to safeguard the health and safety of humans in the hostile environment of space, innovation in pharmaceutical manufacturing and drug delivery deserves urgent attention. In this review/commentary, the current state of medicines provision in space is explored, accompanied by a forward look on the future of pharmaceutical manufacturing in outer space. The hazards associated with spaceflight, and their corresponding medical problems, are first briefly discussed. Subsequently, the infeasibility of present-day medicines provision systems for supporting deep space exploration is examined. The existing knowledge gaps on the altered clinical effects of medicines in space are evaluated, and suggestions are provided on how clinical trials in space might be conducted. An envisioned model of on-site production and delivery of medicines in space is proposed, referencing emerging technologies (e.g. Chemputing, synthetic biology, and 3D printing) being developed on Earth that may be adapted for extra-terrestrial use. This review concludes with a critical analysis on the regulatory considerations necessary to facilitate the adoption of these technologies and proposes a framework by which these may be enforced. In doing so, this commentary aims to instigate discussions on the pharmaceutical needs of deep space exploration, and strategies on how these may be met.

Ulcerative colitis is a global health problem, affecting millions of individuals worldwide. As an inflammatory condition localised in the large intestine, rectal delivery of immunosuppressive therapies such as tacrolimus is a promising strategy to maximise drug concentration at the site of action whilst minimising systemic side effects. Here, for the first time, self-supporting 3D-printed tacrolimus suppositories were prepared without the aid of moulds using a pharmaceutical semi-solid extrusion (SSE) 3D printer. The suppositories were printed vertically in three different sizes using combinations of two lipid pharmaceutical excipients (Gelucire 44/14 or Gelucire 48/16) and coconut oil. Although both suppository formulations had the appropriate viscosity characteristics for printing, the Gel 44 formulation required less energy and force for extrusion compared to the Gel 48 system. The Gel 44 disintegrated more rapidly but released tacrolimus more slowly than the Gel 48 suppositories. Although the tacrolimus release profiles were significantly different, both suppository systems released more than 80% drug within 120 min. DSC and XRD analysis was inconclusive in determining the solid-state properties of the drug in the suppositories. In summary, this article reports on the fabrication of 3D printed self-supporting suppositories to deliver personalised doses of a narrow therapeutic index drug, with potential benefits for patients with ulcerative colitis.

The aim of this study was to fabricate novel self-supporting tacrolimus suppositories using semisolid extrusion 3-dimensional printing (3DP) and to investigate their efficacy in an experimental model of inflammatory bowel disease. Blends of Gelucire 44/14 and coconut oil were employed as lipid excipients to obtain suppository formulations with self-emulsifying properties, which were then tested in a TNBS (2,4,6-trinitrobenzenesulfonic acid) induced rat colitis model. Disease activity was monitored using PET/CT medical imaging; maximum standardized uptake values (SUVmax), a measure of tissue radiotracer accumulation rate, together with body weight changes and histological assessments, were used as inflammatory indices to monitor treatment efficacy. Following tacrolimus treatment, a significant reduction in SUVmax was observed on days 7 and 10 in the rat colon sections compared to non-treated animals. Histological analysis using Nancy index confirmed disease remission. Moreover, statistical analysis showed a positive correlation (R2 = 71.48%) between SUVmax values and weight changes over time. Overall, this study demonstrates the effectiveness of 3D printed tacrolimus suppositories to ameliorate colitis and highlights the utility of non-invasive PET/CT imaging to evaluate new therapies in the preclinical area.

Smart-home installations exponential growth has raised major security concerns. To this direction, the GHOST project, a European Union Horizon 2020 Research and Innovation funded project, aims to develop a reference architecture for securing smart-homes IoT ecosystem. It is required to have automated and user friendly security mechanisms embedded into smart-home environments, to protect the users’ digital well being. GHOST project aims to fulfill this requirement and one of its main functionalities is the traffic monitoring for all IoT related network protocols. In this paper, the traffic capturing and monitoring mechanism of the GHOST system, called NDFA, is presented, as the first mechanism that is able to monitor smart-home activity in a holistic way. With the help of the NDFA, we compile the GHOST-IoT-data-set, an IoT network traffic data-set, captured in a real world smart-home installation. This data-set contains traffic from multiple network interfaces with both normal real life activity and simulated abnormal functioning of the devices. The GHOST-IoT-data-set is offered to the research community as a proof of concept to demonstrate the ability of the NDFA module to process the raw network traffic from a real world smart-home installation with multiple network interfaces and IoT devices.

Following oral administration, gastric emptying is often a rate-limiting step in the absorption of drugs and is dependent on both physiological and pharmaceutical factors. To guide translation into humans, small animal imaging during pre-clinical studies has been increasingly used to localise the gastrointestinal transit of solid dosage forms. In contrast to humans, however, anaesthesia is usually required for effective imaging in animals which may have unintended effects on intestinal physiology. This study evaluated the effect of anaesthesia and capsule size on the gastric emptying rate of coated capsules in rats. Computed tomography (CT) imaging was used to track and locate the capsules through the gastrointestinal tract. Two commercial gelatine mini-capsules (size 9 and 9h) were filled with barium sulphate (contrast agent) and coated using Eudragit L. Under the effect of anaesthesia, none of the capsules emptied from the stomach. In non-anaesthetised rats, most of the size 9 capsules did not empty from the stomach, whereas the majority of the smaller size 9h capsules successfully emptied from the stomach and moved into the intestine. This study demonstrates that even with capsules designed to empty from the stomach in rats, the gastric emptying of such solid oral dosage forms is not guaranteed. In addition, the use of anaesthesia was found to abolish gastric emptying of both capsule sizes. The work herein further highlights the utility of CT imaging for the effective visualisation and location of solid dosage forms in the intestinal tract of rats without the use of anaesthesia.

Introduction: Tuberous sclerosis complex (TSC) is one of the most frequent neurocutaneous disorders. Cortical tubers are the most common pathological changes in TSC and they are directly related to the disease's main clinical manifestations: seizures, mental retardation, and autistic behaviour. Objective: The aim of this study is to establish a correlation between tuber size and the severity of clinical features in TSC. Material and methods: We performed a retrospective study of the clinical and imaging findings from 45 TSC patients (22 females and 23 males) and compared the clinical features with the location, size, and number of the cortical tubers in each patient. Results: Four patients had voluminous tubers located in 1 or both cerebral hemispheres. All of these patients had intractable seizures and severe mental retardation; 3 of these cases also presented with autistic behaviour, despite tubers having been resected in all 4 patients. Thirteen patients had tubers of large-to-average size, and all patients in this group showed intractable seizures and mental retardation. Nine patients who had experienced infantile spasms during the first year of life presented autistic behaviour. Multiple tubers of small to average size were found in 28 patients. In general, this group had seizures that responded well to antiepileptic drugs and a low prevalence of autism. In 3 patients who all presented good seizure control and normal intelligence, single cortical/subcortical tubers were located in the frontal or occipital lobes. Of the total of 45 patients, 13 had cerebellar as well as cerebral tubers; these were generally present in cases with more severe clinical features. Conclusions: Although large tubers are less common than small to medium-sized ones, they are much more likely to be accompanied by severe clinical symptoms (seizures, mental retardation and autistic behaviour), even when the smaller tubers are quite numerous. Resumen: Introducción: El complejo esclerosis tuberosa (CET) es uno de los trastornos neurocutáneos más frecuentes. Las tuberosidades corticales son las alteraciones patológicas más frecuentes y están relacionadas directamente con las principales expresiones clínicas, crisis epilépticas, retraso mental y comportamiento autista. El motivo de este trabajo es mostrar la importancia de los diferentes tipos de tuberosidades en la expresión clínica de los pacientes. Objetivo: La finalidad de este trabajo es relacionar el tamaño de las tuberosidades con la severidad de las alteraciones clínicas. Material y métodos: Se estudiaron retrospectivamente los hallazgos clínicos y neurorradioló-gicos de 45 pacientes infantiles (22 mujeres y 23 varones) con CET y comparamos los hallazgos clínicos con la localización, el tamaño y el número de las tuberosidades corticales en cada paciente. Resultados: Cuatro pacientes tenían tuberosidades muy voluminosas en los hemisferios cere-brales. Todas mostraban crisis epilépticas muy rebeldes y retraso mental profundo con comportamiento autista en 3 de ellos, pese a que se extirparon las tuberosidades en los 4 casos. Trece pacientes tenían tuberosidades de tamaño promedio-grande. Todos tenían crisis epilépticas muy rebeldes y retraso mental. Nueve pacientes habían tenido espasmos infantiles durante el primer año de vida y presentaban comportamiento autista. Veintiocho pacientes mostraban muchas tuberosidades de tamaño promedio-pequeño. La mayoría de ellos tenían crisis con buena respuesta al tratamiento farmacológico y poca prevalencia del autismo. Tres pacientes mostraban tuberosidad córtico-subcortical única en un polo frontal u occipital, todos ellos con crisis controladas con medicación y cociente intelectual normal. Trece pacientes de los 45 tenían tuberosidades cerebelosas, siempre asociadas a algún tipo de tuberosidad hemisférica y generalmente presentes en casos con mayor expresividad clínica. Conclusiones: Las tuberosidades de gran tamaño, aunque sean poco numerosas, tienen mucha mayor relación con la presencia de sintomatología clínica severa—crisis epilépticas, retraso mental y comportamiento autista—que las tuberosidades de pequeño-mediano tamaño, aunque sean muy numerosas. Keywords: Tuberous sclerosis complex, Tubers, Seizures in tuberous sclerosis complex, Autism in tuberous sclerosis complex, Mental retardation in tuberous sclerosis complex, Magnetic resonance imaging in tuberous sclerosis complex, Palabras clave: Complejo esclerosis tuberosa, Tuberosidades, Crisis epilépticas en el complejo esclerosis tuberosa, Autismo en el complejo esclerosis tuberosa, Retraso mental en el complejo esclerosis tuberosa, Resonancia magnética en el complejo esclerosis tuberosa

Resumen: Introducción: El complejo esclerosis tuberosa (CET) es uno de los trastornos neurocutáneos más frecuentes. Las tuberosidades corticales son las alteraciones patológicas más frecuentes y están relacionadas directamente con las principales expresiones clínicas, crisis epilépticas, retraso mental y comportamiento autista. El motivo de este trabajo es mostrar la importancia de los diferentes tipos de tuberosidades en la expresión clínica de los pacientes. Objetivo: La finalidad de este trabajo es relacionar el tamaño de las tuberosidades con la severidad de las alteraciones clínicas. Material y métodos: Se estudiaron retrospectivamente los hallazgos clínicos y neurorradiológicos de 45 pacientes infantiles (22 mujeres y 23 varones) con CET y comparamos los hallazgos clínicos con la localización, el tamaño y el número de las tuberosidades corticales en cada paciente. Resultados: Cuatro pacientes tenían tuberosidades muy voluminosas en los hemisferios cerebrales. Todas mostraban crisis epilépticas muy rebeldes y retraso mental profundo con comportamiento autista en 3 de ellos, pese a que se extirparon las tuberosidades en los 4 casos. Trece pacientes tenían tuberosidades de tamaño promedio-grande. Todos tenían crisis epilépticas muy rebeldes y retraso mental. Nueve pacientes habían tenido espasmos infantiles durante el primer año de vida y presentaban comportamiento autista. Veintiocho pacientes mostraban muchas tuberosidades de tamaño promedio-pequeño. La mayoría de ellos tenían crisis con buena respuesta al tratamiento farmacológico y poca prevalencia del autismo. Tres pacientes mostraban tuberosidad córtico-subcortical única en un polo frontal u occipital, todos ellos con crisis controladas con medicación y cociente intelectual normal. Trece pacientes de los 45 tenían tuberosidades cerebelosas, siempre asociadas a algún tipo de tuberosidad hemisférica y generalmente presentes en casos con mayor expresividad clínica. Conclusiones: Las tuberosidades de gran tamaño, aunque sean poco numerosas, tienen mucha mayor relación con la presencia de sintomatología clínica severa —crisis epilépticas, retraso mental y comportamiento autista— que las tuberosidades de pequeño-mediano tamaño, aunque sean muy numerosas. Abstract: Introduction: Tuberous sclerosis complex (TSC) is one of the most frequent neurocutaneous disorders. Cortical tubers are the most common pathological changes in TSC and they are directly related to the disease's main clinical manifestations: seizures, mental retardation, and autistic behaviour. Objective: The aim of this study is to establish a correlation between tuber size and the severity of clinical features in TSC. Material and methods: We performed a retrospective study of the clinical and imaging findings from 45 TSC patients (22 females and 23 males) and compared the clinical features with the location, size, and number of the cortical tubers in each patient. Results: Four patients had voluminous tubers located in 1 or both cerebral hemispheres. All of these patients had intractable seizures and severe mental retardation; 3 of these cases also presented with autistic behaviour, despite tubers having been resected in all 4 patients. Thirteen patients had tubers of large-to-average size, and all patients in this group showed intractable seizures and mental retardation. Nine patients who had experienced infantile spasms during the first year of life presented autistic behaviour. Multiple tubers of small to average size were found in 28 patients. In general, this group had seizures that responded well to antiepileptic drugs and a low prevalence of autism. In 3 patients who all presented good seizure control and normal intelligence, single cortical/subcortical tubers were located in the frontal or occipital lobes. Of the total of 45 patients, 13 had cerebellar as well as cerebral tubers; these were generally present in cases with more severe clinical features. Conclusions: Although large tubers are less common than small to medium-sized ones, they are much more likely to be accompanied by severe clinical symptoms (seizures, mental retardation and autistic behaviour), even when the smaller tubers are quite numerous. Palabras clave: Complejo esclerosis tuberosa, Tuberosidades, Crisis epilépticas en el complejo esclerosis tuberosa, Autismo en el complejo esclerosis tuberosa, Retraso mental en el complejo esclerosis tuberosa, Resonancia magnética en el complejo esclerosis tuberosa, Keywords: Tuberous sclerosis complex, Tubers, Seizures in tuberous sclerosis complex, Autism in tuberous sclerosis complex, Mental retardation in tuberous sclerosis complex, Magnetic resonance imaging in tuberous sclerosis complex

Resumen: Introducción: El término displasia cortical focal (DCF) expresa una patología muy particular de trastorno de la migración que conlleva una sintomatología caracterizada principalmente por crisis epilépticas fármaco-resistentes, unas imágenes neurorradiológicas y unas características histológicas peculiares, así como una respuesta al tratamiento quirúrgico muy positiva en la mayoría de los casos. Material y métodos: Se estudia a 7 pacientes, 6 niños con edad promedio de 34,3 meses y un varón de 25 años con crisis focales muy rebeldes e imágenes de RM que mostraban DCF. Resultados: Tres de los pacientes (todas niñas) fueron operadas en edades muy tempranas, con extirpación de la DCF y la zona circundante, demostrando el estudio anatómico la concordancia de las imágenes de RM con las macroscópicas de los cortes anatómicos. El estudio histológico mostró los típicos hallazgos de la DCF tipo Taylor (mala delimitación entre sustancia gris cortical y la sustancia blanca subcortical, y «células balonadas»). Tres años después de la resección de la DCF los 3 pacientes estaban curados de las crisis y sin medicación antiepiléptica. Dos de los pacientes están controlados de las crisis con medicación, otro (el adulto) está en espera de decisión quirúrgica y el restante desechó la operación. Conclusión: La DCF tipo Taylor es una patología asociada a una buena parte de las crisis focales fármaco-resistentes, que debe tratarse de identificar y de extirpar lo antes posible ya que la cirugía, bien proyectada y realizada, sin dejar residuos displásicos, puede curarla en un alto porcentaje de casos. Abstract: Introduction: The term focal cortical dysplasia (FCD) describes a particular migration disorder with a symptomatology mainly characterised by drug-resistant epileptic seizures, typical neuroradiological images, and histological characteristics, as well as a very positive response to surgical treatment in the majority of cases. Material and methods: A total of 7 patients were studied, comprising 6 children with a mean age of 34.3 months and one 25-year-old male with very persistent focal seizures and MRI images that showed FCD. Results: Three of the patients (all girls) were operated on while very young, with extirpation of the FCD and the surrounding area; with the histopathology study showed agreement between the MRI images and the macroscopic study of the slices. The histology study showed findings typical of a Taylor-type FCD (poor differentiation between the cortical grey matter and the subcortical white matter, and balloon cells). Three years after the FCD extirpation, the same 3 patients remained seizure-free with no anti-epilepsy medication. Two others have seizure control with medication, another (the adult) is on the surgical waiting list, and the remaining patient refused the operation. Conclusion: Taylor-type FCD is associated with a high percentage of all drug-resistant focal seizures, and it needs to be identified and extirpated as soon as possible. Well planned and well-performed surgery that leaves no remains of dysplasia can cure the disease it in many cases. Palabras clave: Células balonadas, Displasia cortical focal, Displasia cortical focal tipo Taylor, Epilepsia, Epilepsia fármaco-resistente, Tratamiento quirúrgico de la epilepsia, Keywords: Balloon cells, Focal cortical dysplasia, Taylor-type focal cortical dysplasia, Epilepsy, Drug-resistant epilepsy, Surgical treatment of epilepsy

Resumen: Objetivo: Presentar 16 pacientes con esquisencefalia y afectación neurológica recalcando sus características clínicas y de imagen. Material y métodos: Son 16 pacientes, 8 varones y 8 mujeres, todos ellos con edades por debajo de los 3 años al hacerse el diagnóstico de esquisencefalia. En dos casos el diagnóstico se hizo prenatalmente y, en los otros 14, a lo largo de los cinco primeros años de vida. El diagnóstico se hizo por tomografía computarizada (TC) en un caso y por RM tridimensional (RM3D) con un aparato de 1,5 T en los otros casos. Los motivos de la consulta fueron retraso psicomotor, trastornos motores y/o crisis epilépticas en la mayoría de los pacientes. Resultados: La esquisencefalia era de labios abiertos bilaterales en 5 pacientes (dos de ellos por citomegalia durante la gestación), labios abiertos unilaterales en 2 pacientes, 8 mostraban esquisencefalia unilateral de labios cerrados y 1 tenía esquisencefalia de labios abiertos en un lado y cerrados en otro. En dos pacientes se diagnosticó infección prenatal por citomegalovirus y en otros dos se diagnosticó malformación cerebral central prenatal por ecografía rutinaria durante la gestación. Todos los pacientes presentaban algún tipo de deficiencia motriz uni o bilateral. Ocho pacientes padecían crisis epilépticas (50%) parciales en todos los casos y solo en uno de ellos se generalizaban. Este último caso fue el único en el que las crisis no llegaron a ser controladas. Todos los pacientes presentaban algún tipo de deficiencia motriz, generalmente benigna, unilateral (hemiparesia) o bilateral (tetraparesia). Conclusión: La RM3D es muy importante para el diagnóstico de la esquisencefalia ya que permite ver la capa de polimicrogiria que tapiza los labios de la malformación y, por ello, la diferenciación con las cavidades porencefálicas. Alteraciones de la migración, tales como heterotopias y especialmente displasias corticales se observaban en varios pacientes. Un 50% de los pacientes presentaba epilepsia, que fue controlable con medicación en todos los casos menos en uno. Abstract: Objective: To present 16 patients with schizencephaly and neurological involvement, and analyse their characteristics and neuroimages. Material and methods: The study included 16 patients, 8 males and 8 females, all of whom were diagnosed with schizencephaly at less than 3 years of age; 2 patients were diagnosed prenatally. Schizencephaly was identified by computerized tomography (CT) in 1 patient and by MR or three-dimensional MR (3DMR) with a 1.5tesla apparatus in the others. Most patients were referred for evaluation because of psychomotor delay, motor disabilities and/or seizures. Results: Five patients had bilateral schizencephaly with open lips (2 of them had suffered intrauterine cytomegalovirus infections); 2 showed unilateral schizencephaly with separated lips, 8 presented unilateral schizencephaly with fused lips, and 1 had schizencephaly with open lips on one side and fused lips on the other. Prenatal cytomegalovirus infection was diagnosed in 2 patients. A cerebral malformation that affected the midline was diagnosed by routine ultrasound studies in 2 patients. Eight patients (50%) presented with seizures that were focal, except for one patient who showed secondary generalisation. The latter was the only patient whose disease was refractory to complete seizure control with antiepileptic medication. All patients had some degree of motor deficit, which was either unilateral (hemiparesis) or bilateral (tetraparesis). Conclusion: 3D MR imaging was very important in diagnosing of schizencephaly in our patients because it showed the polymicrogyria that covered the area of the cleft and permitted us to rule out porencephaly. Neuronal migration disorders such as heterotopias and, more frequently, cortical dysplasias, were observed in several patients. Half of the patients had epilepsy which was controlled with antiepileptic medication, except in 1 patient. Palabras clave: Esquisencefalia, Trastornos de la migración neuronal, Trastornos de la organización cortical, Epilepsia, Resonancia magnética tridimensional, Déficit motor, Displasia cortical, Keywords: Schizencephaly, Migration disorders, Cortical organization disorders, Epilepsy, Three-dimensional MR, Motor deficit, Cortical dysplasia

Objective: To present 16 patients with schizencephaly and neurological involvement, and analyse their characteristics and neuroimages. Material and methods: The study included 16 patients, 8 males and 8 females, all of whom were diagnosed with schizencephaly at less than 3 years of age; 2 patients were diagnosed prenatally. Schizencephaly was identified by computerised tomography (CT) in 1 patient and by MR or three-dimensional MR (3DMR) with a 1.5 tesla apparatus in the others. Most patients were referred for evaluation because of psychomotor delay, motor disabilities and/or seizures. Results: Five patients had bilateral schizencephaly with open lips (2 of them had suffered intrauterine cytomegalovirus infections); 2 showed unilateral schizencephaly with separated lips, 8 presented unilateral schizencephaly with fused lips, and 1 had schizencephaly with open lips on one side and fused lips on the other. Prenatal cytomegalovirus infection was diagnosed in 2 patients. A cerebral malformation that affected the midline was diagnosed by routine ultrasound studies in 2 patients. Eight patients (50%) presented with seizures that were focal, except for one patient who showed secondary generalisation. The latter was the only patient whose disease was refractory to complete seizure control with antiepileptic medication. All patients had some degree of motor deficit, which was either unilateral (hemiparesis) or bilateral (tetraparesis). Conclusion: 3DMR imaging was very important in diagnosing of schizencephaly in our patients because it showed the polymicrogyria that covered the area of the cleft and permitted us to rule out porencephaly. Neuronal migration disorders such as heterotopias and, more frequently, cortical dysplasias, were observed in several patients. Half of the patients had epilepsy which was controlled with antiepileptic medication, except in 1 patient. Resumen: Objetivo: Presentar 16 pacientes con esquisencefalia y afectación neurológica recalcando sus características clínicas y de imagen. Material y métodos: Son 16 pacientes, 8 varones y 8 mujeres, todos ellos con edades por debajo de los 3 años al hacerse el diagnóstico de esquisencefalia. En dos casos el diagnóstico se hizo prenatalmente y, en los otros 14, a lo largo de los cinco primeros años de vida. El diagnóstico se hizo por tomografía computarizada (TC) en un caso y por RM tridimensional (RM3D) con un aparato de 1,5 T en los otros casos. Los motivos de la consulta fueron retraso psicomotor, trastornos motores y/o crisis epilépticas en la mayoría de los pacientes. Resultados: La esquisencefalia era de labios abiertos bilaterales en 5 pacientes (dos de ellos por citomegalia durante la gestación), labios abiertos unilaterales en 2 pacientes, 8 mostraban esquisencefalia unilateral de labios cerrados y 1 tenía esquisencefalia de labios abiertos en un lado y cerrados en otro. En dos pacientes se diagnosticó infección prenatal por citomegalovirus y en otros dos se diagnosticó malformación cerebral central prenatal por ecografía rutinaria durante la gestación. Todos los pacientes presentaban algún tipo de deficiencia motriz uni o bilateral. Ocho pacientes padecían crisis epilépticas (50%) parciales en todos los casos y solo en uno de ellos se generalizaban. Este último caso fue el único en el que las crisis no llegaron a ser controladas. Todos los pacientes presentaban algún tipo de deficiencia motriz, generalmente benigna, unilateral (hemiparesia) o bilateral (tetraparesia). Conclusión: La RM3D es muy importante para el diagnóstico de la esquisencefalia ya que permite ver la capa de polimicrogiria que tapiza los labios de la malformación y, por ello, la diferenciación con las cavidades porencefálicas. Alteraciones de la migración, tales como heterotopias y especialmente displasias corticales se observaban en varios pacientes. Un 50% de los pacientes presentaba epilepsia, que fue controlable con medicación en todos los casos menos en uno. Keywords: Schizencephaly, Migration disorders, Cortical organization disorders, Epilepsy, Three-dimensional MR, Motor deficit, Cortical dysplasia, Palabras clave: Esquisencefalia, Trastornos de la migración neuronal, Trastornos de la organización cortical, Epilepsia, Resonancia magnética tridimensional, Déficit motor, Displasia cortical

Introduction: The term focal cortical dysplasia (FCD) describes a particular migration disorder with a symptomatology mainly characterised by drug-resistant epileptic seizures, typical neuroradiological images, and histological characteristics, as well as a very positive response to surgical treatment in the majority of cases. Material and methods: A total of 7 patients were studied, comprising 6 children with a mean age of 34.3 months and one 25-year-old male with very persistent focal seizures and MRI images that showed FCD. Results: Three of the patients (all girls) were operated on while very young, with extirpation of the FCD and the surrounding area; with the histopathology study showed agreement between the MRI images and the macroscopic study of the slices. The histology study showed findings typical of a Taylor-type FCD (poor differentiation between the cortical grey matter and the subcortical white matter, and balloon cells). Three years after the FCD extirpation, the same 3 patients remained seizure-free with no anti-epilepsy medication. Two others have seizure control with medication, another (the adult) is on the surgical waiting list, and the remaining patient refused the operation. Conclusion: Taylor-type FCD is associated with a high percentage of all drug-resistant focal seizures, and it needs to be identified and extirpated as soon as possible. Well planned and well-performed surgery that leaves no remains of dysplasia can cure the disease it in many cases. Resumen: Introducción: El término displasia cortical focal (DCF) expresa una patología muy particular de trastorno de la migración que conlleva una sintomatología caracterizada principalmente por crisis epilépticas fármaco-resistentes, unas imágenes neurorradiológicas y unas características histológicas peculiares, así como una respuesta al tratamiento quirúrgico muy positiva en la mayoría de los casos. Material y métodos: Se estudia a 7 pacientes, 6 niños con edad promedio de 34,3 meses y un varón de 25 años con crisis focales muy rebeldes e imágenes de RM que mostraban DCF. Resultados: Tres de los pacientes (todas niñas) fueron operadas en edades muy tempranas, con extirpación de la DCF y la zona circundante, demostrando el estudio anatómico la concordancia de las imágenes de RM con las macroscópicas de los cortes anatómicos. El estudio histológico mostró los típicos hallazgos de la DCF tipo Taylor (mala delimitación entre sustancia gris cortical y la sustancia blanca subcortical, y «células balonadas»). Tres años después de la resección de la DCF los 3 pacientes estaban curados de las crisis y sin medicación antiepiléptica. Dos de los pacientes están controlados de las crisis con medicación, otro (el adulto) está en espera de decisión quirúrgica y el restante desechó la operación. Conclusión: La DCF tipo Taylor es una patología asociada a una buena parte de las crisis focales fármaco-resistentes, que debe tratarse de identificar y de extirpar lo antes posible ya que la cirugía, bien proyectada y realizada, sin dejar residuos displásicos, puede curarla en un alto porcentaje de casos. Keywords: Balloon cells, Focal cortical dysplasia, Taylor-type focal cortical dysplasia, Epilepsy, Drug-resistant epilepsy, Surgical treatment of epilepsy, Palabras clave: Células balonadas, Displasia cortical focal, Displasia cortical focal tipo Taylor, Epilepsia, Epilepsia fármaco-resistente, Tratamiento quirúrgico de la epilepsia

Resumen: Introducción: La infección intrauterina por citomegalovirus es la más frecuente de las viriasis/parasitosis intrauterinas que afectan al sistema nervioso central y causan lesiones permanentes tanto en el córtex como en la sustancia blanca subcortical. Son escasos los estudios de resonancia magnética (RM) cerebral. Material y métodos: Seis pacientes (4 M y 2 V) fueron estudiados desde los primeros meses de vida para hacer el diagnóstico de citomegalia congénita e identificar la presencia de lesiones corticales y subcorticales, utilizando las necesarias secuencias de RM. Resultados: Los 6 pacientes mostraban malformaciones del desarrollo cortical (MDC) (esquisencefalia, polimicrogiria o lisencefalia-paquigiria) desde la época neonatal y alteraciones difusas de la sustancia blanca, que se mantuvieron con pocos cambios durante los dos primeros años y después se iban reduciendo de tamaño en forma de zonas de hiperseñal en T2, circunscritas a determinadas áreas y permanecían con pocos cambios durante algunos años más. Conclusión: La infección intrauterina por citomegalovirus causa lesiones en sustancia gris cortical, que consisten en MDC y en sustancia blanca subcortical. Estas últimas muestran aspecto cambiante, ya que aparecen como áreas difusas y amplias de hiperseñal, que se suelen interpretar como retraso en la mielinización, pero que también pueden ser causadas directamente por el virus de la citomegalia. Estas alteraciones de la sustancia blanca sufren cambios morfológicos a lo largo de los primeros años de vida, dejando atrofia cerebral. Las secuelas neurológicas que dejan estas alteraciones son severas y crónicas. Abstract: Introduction: Intrauterine infection due to cytomegalovirus is the most common of the intrauterine viral/parasitic infections that affect the central nervous system and cause permanent lesions in the cortex as well as the subcortical white matter. Studies using brain magnetic resonance imaging (MRI) are limited. Material and methods: Six patients (4 females and 2 males) were studied in the first months of life in order to make a diagnosis of congenital cytomegalovirus, and identify the cortical and subcortical lesions using the necessary MRI sequences. Results: The six patients showed malformations of cortical development (MDC) (schizencephaly, polymicrogyria or lissencephaly-pachygyria) from the neonatal period, and diffuse changes of the white matter, which remained with few changes during the first two years. They then began reducing in size in the form of high signal areas in T2, restricted to certain areas, and were evident for a few years more with little change. Conclusion: Intrauterine infection due to cytomegalovirus causes changes in the cortical grey matter, which consists of MDC, and in the subcortical white matter. The latter show a changing aspect as they appear as diffuse and wide areas of high signal intensity, which is usually due to delay in myelinisation, but could also be caused directly by the cytomegalovirus. These changes in the white matter are subjected to morphological changes throughout the first years of life, leading to brain atrophy. The neurological sequelae of these lesions left by these alterations are severe and chronic. Palabras clave: Citomegalia, Encefalopatía por citomegalia, Esquisencefalia, Lisencefalia-paquigiria por citomegalia, Polimicrogiria por citomegalia, Keywords: Cytomegaly, Encephalopathy due to cytomegaly, Schizencephaly, Lissencephaly-pachygyria due to cytomegaly, Polymicrogyria due to cytomegaly

Introduction: Intrauterine infection due to cytomegalovirus is the most common of the intrauterine viral/parasitic infections that affect the central nervous system (CNS) and cause permanent lesions in the cortex as well as the subcortical white matter. Studies using brain magnetic resonance imaging (MRI) are limited. Material and methods: Six patients (4 females and 2 males) were studied in the first months of life in order to make a diagnosis of congenital cytomegalovirus, and identify the cortical and subcortical lesions using the necessary MRI sequences. Results: The six patients showed malformations of cortical development (MCD) (schizencephaly, polymicrogyria or lissencephaly-pachygyria) from the neonatal period, and diffuse changes of the white matter, which remained with few changes during the first two years. They then began reducing in size in the form of high signal areas in T2, restricted to certain areas, and were evident for a few years more with little change. Conclusion: Intrauterine infection due to cytomegalovirus causes changes in the cortical grey matter, which consists of MCD, and in the subcortical white matter. The latter show a changing aspect as they appear as diffuse and wide areas of high signal intensity, which is usually due to delay in myelinisation, but could also be caused directly by the cytomegalovirus. These changes in the white matter are subjected to morphological changes throughout the first years of life, leading to brain atrophy. The neurological sequelae of these lesions left by these alterations are severe and chronic. Resumen: Introducción: La infección intrauterina por citomegalovirus es la más frecuente de las viriasis/parasitosis intrauterinas que afectan al sistema nervioso central y causan lesiones permanentes tanto en el córtex como en la sustancia blanca subcortical. Son escasos los estudios de resonancia magnética (RM) cerebral. Material y métodos: Seis pacientes (4 M y 2 V) fueron estudiados desde los primeros meses de vida para hacer el diagnóstico de citomegalia congénita e identificar la presencia de lesiones corticales y subcorticales, utilizando las necesarias secuencias de RM. Resultados: Los 6 pacientes mostraban malformaciones del desarrollo cortical (MDC) (esquisencefalia, polimicrogiria o lisencefalia-paquigiria) desde la época neonatal y alteraciones difusas de la sustancia blanca, que se mantuvieron con pocos cambios durante los dos primeros años y después se iban reduciendo de tamaño en forma de zonas de hiperseñal en T2, circunscritas a determinadas áreas y permanecían con pocos cambios durante algunos años más. Conclusión: La infección intrauterina por citomegalovirus causa lesiones en sustancia gris cortical, que consisten en MCD y en sustancia blanca subcortical. Estas últimas muestran aspecto cambiante, ya que aparecen como áreas difusas y amplias de hiperseñal, que se suelen interpretar como retraso en la mielinización, pero que también pueden ser causadas directamente por el virus de la citomegalia. Estas alteraciones de la sustancia blanca sufren cambios morfológicos a lo largo de los primeros años de vida, dejando atrofia cerebral. Las secuelas neurológicas que dejan estas alteraciones son severas y crónicas. Keywords: Cytomegaly, Encephalopathy due to cytomegaly, Schizencephaly, Lissencephaly-pachygyria due to cytomegaly, Polymicrogyria due to cytomegaly, Palabras clave: Citomegalia, Encefalopatía por citomegalia, Esquisencefalia, Lisencefalia-paquigiria por citomegalia, Polimicrogiria por citomegalia

Resumen: Objetivo: Presentar 8 pacientes con astrocitomas subependimarios de células gigantes (ASGC) en relación con el complejo de esclerosis tuberosa (CET). Material y métodos: Ocho pacientes, 6 varones y 2 mujeres, con CET, que desarrollaron el tumor entre la etapa neonatal y los 24 años. Resultados: Todos mostraban áreas localizadas bilaterales de hiperseñal, en zonas próximas a los foramina de Monro. Tres ingresaron urgentemente con ceguera e hipertensión intracraneal. La extirpación parcial del tumor fue siempre una mala solución ya que acabó en reintervenciones a corto, medio o largo plazo o en la muerte de un paciente. Sólo en un caso vimos desarrollarse el tumor desde las zonas de hiperseñal subependimaria a partir de la preadolescencia para acabar en extirpación a los 24 años, mientras que 32 pacientes a los que se siguió la evolución de estas zonas de hiperseñal entre 10 y 30 años no desarrollaron tumor. Un paciente tuvo que ser operado cuatro veces a lo largo de 20 años por recidiva del tumor; se extirpó otro ASGC en el lado contralateral al mismo tiempo de la cuatra intervención en el lado del tumor primitivo. Otros 2 pacientes también mostraron recidiva y tuvieron que ser reintervenidos del tumor. Conclusiones: El ASGC en relación con CET es una complicación grave cuya posibilidad de desarrollo hay que controlar cuidadosamente desde la época neonatal, con estudios periódicos clínicos y de imagen, para evitar sus complicaciones irreversibles. La hidrocefalia, la ceguera e incluso la muerte pueden ser sus consecuencias. La reintervención de tumores recidivados a menudo es necesaria. Abstract: Objective: Presentation of 8 patients with subependymal giant-cell astrocytomas (SGCA) associated with tuberous sclerosis complex (TSC). Material and methods: There are 8 patients, 6 males and 2 females with TSC, who presented with the tumour between the neonatal period and 24 years. Results: All patients showed bilateral hypersignalised areas in zones close to the foramen of Monro. Three of the patients were admitted urgently due to blindness and increased intracranial pressure. Incomplete removal of the tumour has always been bad solution as it resulted in the death of the patient (in one case) or further surgery operation in the short term. Only one patient developed the tumour suddenly from pre-existing subependymal nodules from the childhood and they had to be removed at 24 years of age. By contrast, 32 patients with TSC and images of subependymal nodules whose CT or MR progress was followed up for between 10 and 30 years did not develop a tumour. One patient had to be operated four times over 20 years. Conclusions: SGCA associated with TSC is a severe complication which as likely to develop and careful monitoring is required from neonatal age with periodicclinical and imaging studies in order to avoid its irreversible complications. Hydrocephaly, blindness and even the death can be the main consequences. Reintervention of the recurrent tumour is often necessary. Palabras clave: Astrocitoma subependimario de células gigantes, Complejo de esclerosis tuberosa, Cegura, Cefalea, Hidrocefalia, Keywords: Subependymal giant-cell astrocytoma, Tuberous sclerosis complex, Blindness, Headache, Hydrocephalus

Objective: Presentation of 8 patients with subependymal giant-cell astrocytomas (SGCA) associated with tuberous sclerosis complex (TSC). Material and methods: There are 8 patients, 6 males and 2 females with TSC, who presented with the tumour between the neonatal period and 24 years. Results: All patients showed bilateral hypersignalised areas in zones close to the foramen of Monro. Three of the patients were admitted urgently due to blindness and increased intracranial pressure. Incomplete removal of the tumour has always been bad solution as it resulted in the death of the patient (in one case) or further surgery operation in the short term. Only one patient developed the tumour suddenly from pre-existing subependymal nodules from the childhood and they had to be removed at 24 years of age. By contrast, 32 patients with TSC and images of subependymal nodules whose CT or MR progress was followed up for between 10 and 30 years did not develop a tumour. One patient had to be operated four times over 20 years. Conclusions: SGCA associated with TSC is a severe complication which as likely to develop and careful monitoring is required from neonatal age with periodic-clinical and imaging studies in order to avoid its irreversible complications. Hydrocephaly, blindness and even the death can be the main consequences. Reintervention of the recurrent tumour is often necessary. Resumen: Objetivo: Presentar 8 pacientes con astrocitomas subependimarios de células gigantes (ASGC) en relación con el complejo de esclerosis tuberosa (CET). Material y métodos: Ocho pacientes, 6 varones y 2 mujeres, con CET, que desarrollaron el tumor entre la etapa neonatal y los 24 años. Resultados: Todos mostraban áreas localizadas bilaterales de hiperseñal, en zonas próximas a los foramina de Monro. Tres ingresaron urgentemente con ceguera e hipertensión intracraneal. La extirpación parcial del tumor fue siempre una mala solución ya que acabó en reintervenciones a corto, medio o largo plazo o en la muerte de un paciente. Sólo en un caso vimos desarrollarse el tumor desde las zonas de hiperseñal subependimaria a partir de la preadolescencia para acabar en extirpación a los 24 años, mientras que 32 pacientes a los que se siguió la evolución de estas zonas de hiperseñal entre 10 y 30 años no desarrollaron tumor. Un paciente tuvo que ser operado cuatro veces a lo largo de 20 años por recidiva del tumor; se extirpó otro ASGC en el lado contralateral al mismo tiempo de la cuarta intervención en el lado del tumor primitivo. Otros 2 pacientes también mostraron recidiva y tuvieron que ser reintervenidos del tumor. Conclusiones: El ASGC en relación con CET es una complicación grave cuya posibilidad de desarrollo hay que controlar cuidadosamente desde la época neonatal, con estudios periódicos clínicos y de imagen, para evitar sus complicaciones irreversibles. La hidrocefalia, la ceguera e incluso la muerte pueden ser sus consecuencias. La reintervención de tumores recidivados a menudo es necesaria. Keywords: Subependymal giant-cell astrocytoma, Tuberous sclerosis complex, Blindness, Headache, Hydrocephalus, Palabras clave: Astrocitoma subependimario de células gigantes, Complejo de esclerosis tuberosa, Ceguera, Cefalea, Hidrocefalia

Diabetes mellitus is a major health problem with increasing prevalence at a global level. The discovery of insulin in the early 1900s represented a major breakthrough in diabetes management, with further milestones being subsequently achieved with the identification of glucagon-like peptide-1 (GLP-1) and the introduction of GLP-1 receptor agonists (GLP-1 RAs) in clinical practice. Moreover, the subcutaneous delivery of biotherapeutics is a well-established route of administration generally preferred over the intravenous route due to better patient compliance and prolonged drug absorption. However, current subcutaneous formulations of GLP-1 RAs present pharmacokinetic problems that lead to adverse reactions and treatment discontinuation. In this review, we discuss the current challenges of subcutaneous administration of peptide-based therapeutics and provide an overview of the formulations available for the different routes of administration with improved bioavailability and reduced frequency of administration. This review summarises the current challenges of subcutaneous administration of peptide-based antidiabetics and provides an overview of the formulations available for the different routes of administration. [Display omitted] [ABSTRACT FROM AUTHOR]

An abstract is presented of the article "Home Advantage in Elite Handball: The Impact of the Quality of Opposition on Team Performance" by Carlos Lago-Peatas, Miguel A. Gamez, Jorge Viato, Ivan Gonzalez-Garcia, and Maria de Fernandez-Villarino.